Ah, them's fightin' words.But I see you're from CanLyme -- what a terrific site that is. So you must be an OK guy.
Interesting to note that in Pub Med there are 19 returns on PLDS, 3 returns on P-TLDS, and 6482 on "Lyme Disease".
Found these. PTLDS/PLDS is not specifically mentioned in the abstracts, but the concept is clearly there. The phrase itself may be in the paper, dunno.
Scand J Infect Dis Suppl. 1991;77:143-4. Related Articles, Links
Antibiotic susceptibility of Borrelia burgdorferi in vitro and in animal models.
Wretlind B, Johnson RC, Hansen K, Preac-Mursic V.
Department of Clinical Bacteriology, Danderyd Hospital, Sweden.
The development of a rational antibiotic therapy for Lyme borreliosis has been hampered by the lack of reliable microbiologic or serologic criteria for diagnosis or cure. In studies of the treatment, the clinical response, has been used as the primary indicator of efficacy. Studies often differ in their criteria for a successful outcome, and it is not clear whether persistent symptoms are due to incomplete eradication of the pathogen, to a post-infectious syndrome, or to erroneous diagnosis in the first place. Thus, laboratory experiments are needed as a complement to clinical trials.
++++++++++++++++++
Current recommendations for the treatment of Lyme disease. 1992
Sigal LH.
Lyme Disease Center, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick.
Lyme disease is a multisystem inflammatory disease caused by infection with Borrelia burgdorferi. Soon after the tick bite which transmits the infection, the pathognomonic skin rash erythema chronicum migrans occurs in 50 to 70% of patients, often with associated symptoms resembling a 'summer cold' or viral infection. Therapy for this stage of disease consists of 3 to 4 weeks of oral therapy. The agents currently used are: amoxicillin (500 mg 3 or 4 times daily) with or without probenecid 500 mg 3 times daily, doxycycline (100 mg twice daily), or tetracycline (500 mg 4 times daily). Longer duration therapy has never been evaluated and therefore is not currently indicated. Even patients with severe early manifestations of Lyme disease should be treated orally. Later features of Lyme disease include carditis and neurological disease, which can occur days to approximately 9 months after the onset of illness, and arthritis and neurological disease which can occur weeks to years after the onset of the illness. Treatment at this stage is with 2 to 3 weeks of intravenous antibiotics, currently cefotaxime (3 g every 12 hours), ceftriaxone (1 g every 12 hours or 2 g every day) and benzylpenicillin (14 g in divided doses). There is no evidence that longer duration therapy is indicated or more efficacious. The exception to this suggestion is the patient with isolated facial seventh cranial nerve palsy; if such a patient has no other signs or symptoms to suggest Lyme disease and has normal spinal fluid, oral therapy is usually sufficient, although some physicians will give concomitant corticosteroids to hasten the resolution of the palsy. Of major consequence to the practitioner and patient is the possibility that persistent symptoms (e.g. fibromyalgia) may be caused by a process which is no longer antibiotic-sensitive. Special care in the management of so-called 'chronic Lyme disease' is crucial lest the clinician prescribes prolonged or unending courses of antibiotics for such noninfectious problems.
Publication Types:
* Review
* Review, Tutorial
++++++++++++++++++
Clin Dermatol. 1993 Jul-Sep;11(3):393-400. Related Articles, Links
Neurologic manifestations in Lyme borreliosis.
Kristoferitsch W.
Department of Neurology, SMZ-OST Krankenhaus, Vienna, Austria.
Publication Types:
* Review
* Review, Tutorial
PMID: 8221521 [PubMed - indexed for MEDLINE] (no abstract, but returned on the phrase Post Lyme Disease Syndrome)
+++++++++++++++++++++++++++++++
Check out Steere's references in the article at this link http://www.biomedcentral.com/content/pdf/cto-id3112.pdf
The references are probably not online (either because they're in book form, or it's so early in internet history) but some of the topics are fascinating and there are references to PLDS, but I don't know if that term is used in the articles themselves. The references include:
Further research on the post-Lyme disease syndrome casts some light on long-term cognitive dysfunction in these patients.
32. Shadick N, Phillips C, Logigian E, et al.: The longterm clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern
Med 1994, 121:560-567.
33. Sigal L: Persisting complaints of Lyme disease: a conceptual review. Am J Med 1994, 96:365-374
OK, now I'm PO'd. I should'nt research stuff like this when I have insomnia, I'll never get to sleep.
[This message has been edited by minoucat (edited 30 January 2005).]